+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Garcinia - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • PDF Icon

    Report

  • 150 Pages
  • October 2026
  • Region: Global
  • Mordor Intelligence
  • ID: 6293128
The garcinia market size was projected to expand from USD 308.67 million in 2025 to USD 337.59 million by 2026 and USD 530.24 million by 2031, registering a CAGR of 9.45% between 2026 and 2031. This report is Segmented by Form (Powder, Liquid), Application (Food and Beverages, Dietary Supplements, Cosmetics and Personal Care, Sports Nutrition Products, Pharmaceuticals), and Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa). The Market Forecasts are Provided in Terms of Value (USD).

Global Garcinia Market Trends and Insights

Mainstream Popularity of HCA-Standardized Extracts

The Garcinia market increasingly separates suppliers that can document HCA content from those that cannot. HPLC-confirmed purity, stable salt chemistry, and clinical support are becoming important requirements in OEM procurement because customers need a dependable starting point for claims, formulation, and quality reviews. Sabinsa offers Citrin®, standardized to 50% free HCA in calcium, magnesium, and potassium salt variants, and GarCitrin®, which combines HCA with 5% to 7% garcinol. These formats give formulators choices that are relevant to dissolution, dosage design, and the intended consumption format. Beverage-grade HCA potassium salt also requires appropriate food-use documentation and solubility performance, which commodity material may not consistently provide. The result is a wider commercial gap between validated extracts and undifferentiated supply, with verified ingredients better suited to contracts that require technical files and routine batch records.

Growing Obesity and Weight-Management Supplement Uptake

Despite mixed clinical evidence surrounding the efficacy of garcinia, the global rise in obesity rates is fueling a growing demand for botanical solutions aimed at weight management. According to the Centers for Disease Control and Prevention data from 2024, obesity prevalence in the United States among adults aged 20-29 was 39.8% . Meta-analytical studies indicate that while the effects are modest, they are statistically significant: garcinia supplementation has been shown to reduce serum leptin levels by 5.01 ng/ml when compared to a placebo. This biochemical action lends credence to claims of appetite suppression. Garcinia retains an advantage from its established retail presence and consumer recognition relative to newer ingredients that still need to build familiarity and distribution. WHO guidance published in 2025 supported GLP-1 therapy as part of comprehensive obesity care, rather than as a standalone intervention. This leaves room for products positioned around natural wellness, maintenance, and complementary routines, even as prescription therapies shape the broader weight-management conversation.

Regulatory Alerts on Hepatotoxicity Cases

Regulatory bodies worldwide are raising alarms over liver injuries linked to garcinia, reshaping the market landscape. In March 2025, France's ANSES released detailed advisories, highlighting 38 severe adverse effects tied to garcinia. These included not only liver complications but also psychiatric and cardiac issues, with one case tragically resulting in death due to acute hepatitis. Echoing these concerns, Australia's Therapeutic Goods Administration cautioned about the rare yet grave risks of liver injuries, pointing out instances severe enough to necessitate hospitalization and even liver transplants . Clinical reports, such as those by Ferreira and Victor, have documented several cases of acute hepatitis and autoimmune hepatitis, some progressing to severe liver failure and transplantation after garcinia consumption. Such regulatory interventions pose formidable challenges for the market, hinting at potential product recalls, stringent labeling mandates, and a dip in consumer trust within the botanical supplement industry.

Other drivers and restraints analyzed in the report include:
  • Retailer Push for Clean-Label Botanical Ingredients
  • Patented Microencapsulation Improving Bioavailability
  • Competition From Synthetic GLP-1 Weight-Loss Drugs

Segment Analysis

Powder accounted for 44.23% of the category in 2025, reflecting its established use in capsule, tablet, and dry-blend supplement manufacturing within the Garcinia market. The format fits existing contract-manufacturing equipment and the familiar serving formats used by long-standing weight-management products, which continues to support its role in the Garcinia market. Particle size, moisture content, and the chosen HCA salt influence blending, storage, and finished-product consistency. Calcium and potassium HCA salts provide stronger hygroscopic stability than free-acid forms, which can simplify handling in dry formulations. Suppliers commonly distinguish powder offerings through HPLC-verified batches, certificate-of-analysis documentation, and dependable delivery specifications.

Liquid is forecast to grow at a 10.05% CAGR through 2031, making it the fastest-growing form in the Garcinia market. Functional beverage manufacturers can use food-appropriate HCA potassium salt grades in ready-to-drink products, teas, and other drinkable wellness formats. Sabinsa identifies Citrin®K Beverage Grade as a potassium salt matrix standardized to 50% to 60% HCA and supported by GRAS affirmation. This positioning is relevant to food applications, where solubility, stable sensory performance, and regulatory documentation influence formulation decisions. Softgel-compatible oil dispersions, tinctures, and spray-dried liquid concentrates serve narrower sports nutrition and cosmetics applications, but they also show how delivery preferences are expanding beyond conventional pills.

Complete Report Scope:

  • Form
    • Powder
    • Liquid
  • Application
    • Food and Beverages
    • Dietary Supplements
    • Cosmetics and Personal Care
    • Sports Nutrition Products
    • Pharmaceuticals
  • By Geography
    • North America
      • United States
      • Canada
      • Mexico
      • Rest of North America
    • Europe
      • Germany
      • France
      • United Kingdom
      • Netherlands
      • Italy
      • Rest of Europe
    • Asia-Pacific
      • China
      • India
      • Japan
      • Australia
      • Rest of Asia-Pacific
    • South America
    • Middle East and Africa

Geography Analysis

North America held 36.03% of the Garcinia market size in 2025. Mature supplement retail infrastructure and strong consumer recognition of Garcinia cambogia support the region's leading position. Premium-certified ingredients can command stronger prices where consumers and OEMs place value on documented formulation quality. The United States has a developed retail and direct-to-consumer base for weight-management products, although suppliers face closer attention to product safety and label compliance. Mexico and other North American markets add secondary volume, while cross-border e-commerce continues to blur established retail boundaries and widen access to the Garcinia market.

Europe has a divided regulatory and commercial environment, and France's suspension of Garcinia cambogia supplements and the UK draft safety opinion have created substantial uncertainty for suppliers and retailers. An adverse European Food Safety Authority assessment could further limit access in the region. Certified organic and clean-label botanicals still appeal to consumers, which rewards companies that can document raw-material provenance, manufacturing controls, and sustainability practices in the Garcinia market. Indena’s ISO-certified manufacturing and photovoltaic investment illustrate the supplier positioning needed to maintain retailer access in a tighter European environment.

Asia-Pacific is expected to grow at an 11.34% CAGR through 2031. India’s southwestern states account for more than 50% of global Garcinia fruit supply, giving the region a material sourcing advantage. South Korea recognizes Garcinia extract as a functional ingredient for body fat reduction, although warning labels and dosage requirements have tightened. The Garcinia market benefits from expanding supplement consumption in India, South Korea, Japan, and Australia. Indian extraction hubs are investing in pharmaceutical-grade GMP facilities to capture higher-value export demand, while South America and the Middle East and Africa remain earlier-stage markets supported by growing online access and health awareness.


List of Companies Covered in this Report:

  • Givaudan (Naturex)
  • Sabinsa Corporation
  • Indena S.p.A.
  • OmniActive Health Technologies
  • Nutraceutical Int’l Corp.
  • BioGanix
  • Botanic Healthcare
  • Shaanxi NHK Technology
  • Nexira
  • Haldin Natural
  • Hindustan Herbals
  • Risun Bio-Tech
  • Bio-Botanica
  • Glanbia Nutritionals
  • Ambe Organic
  • Pure Encapsulations
  • Sarv Biolabs
  • Nutribiotech
  • HAOZE Bio
  • Shreeji Pharma International

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION
1.1 Study Assumptions & Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY3 EXECUTIVE SUMMARY
4 MARKET LANDSCAPE
4.1 Market Overview
4.2 Market Drivers
4.2.1 Mainstream Popularity of HCA-Standardized Extracts
4.2.2 Growing Obesity and Weight-Management Supplement Uptake
4.2.3 Retailer Push for Clean-Label Botanical Ingredients
4.2.4 Patented Microencapsulation Improving Bioavailability
4.2.5 Advancements in Garcinia Extraction Technologies
4.2.6 Rising Use in Functional Beverages and Foods
4.3 Market Restraints
4.3.1 Regulatory Alerts on Hepatotoxicity Cases
4.3.2 Supply Chain Fraud/HCA Content Mis-Labelling
4.3.3 Rising Scrutiny of Carbon Footprint for Tropical Botanicals
4.3.4 Competition From Synthetic GLP-1 Weight-Loss Drugs
4.4 Supply-Chain Analysis
4.5 Regulatory and Technological Outlook
4.6 Porter’s Five Forces
4.6.1 Threat of New Entrants
4.6.2 Bargaining Power of Buyers/Consumers
4.6.3 Bargaining Power of Suppliers
4.6.4 Threat of Substitute Products
4.6.5 Intensity of Competitive Rivalry
5 MARKET SIZE AND GROWTH FORECASTS
5.1 Form
5.1.1 Powder
5.1.2 Liquid
5.2 Application
5.2.1 Food and Beverages
5.2.2 Dietary Supplements
5.2.3 Cosmetics and Personal Care
5.2.4 Sports Nutrition Products
5.2.5 Pharmaceuticals
5.3 By Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.1.4 Rest of North America
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 France
5.3.2.3 United Kingdom
5.3.2.4 Netherlands
5.3.2.5 Italy
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 India
5.3.3.3 Japan
5.3.3.4 Australia
5.3.3.5 Rest of Asia-Pacific
5.3.4 South America
5.3.5 Middle East and Africa
6 COMPETITIVE LANDSCAPE
6.1 Market Concentration
6.2 Strategic Moves
6.3 Market Ranking Analysis
6.4 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
6.4.1 Givaudan (Naturex)
6.4.2 Sabinsa Corporation
6.4.3 Indena S.p.A.
6.4.4 OmniActive Health Technologies
6.4.5 Nutraceutical Int’l Corp.
6.4.6 BioGanix
6.4.7 Botanic Healthcare
6.4.8 Shaanxi NHK Technology
6.4.9 Nexira
6.4.10 Haldin Natural
6.4.11 Hindustan Herbals
6.4.12 Risun Bio-Tech
6.4.13 Bio-Botanica
6.4.14 Glanbia Nutritionals
6.4.15 Ambe Organic
6.4.16 Pure Encapsulations
6.4.17 Sarv Biolabs
6.4.18 Nutribiotech
6.4.19 HAOZE Bio
6.4.20 Shreeji Pharma International
7 MARKET OPPORTUNITIES AND FUTURE OUTLOOK

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Givaudan (Naturex)
  • Sabinsa Corporation
  • Indena S.p.A.
  • OmniActive Health Technologies
  • Nutraceutical Int’l Corp.
  • BioGanix
  • Botanic Healthcare
  • Shaanxi NHK Technology
  • Nexira
  • Haldin Natural
  • Hindustan Herbals
  • Risun Bio-Tech
  • Bio-Botanica
  • Glanbia Nutritionals
  • Ambe Organic
  • Pure Encapsulations
  • Sarv Biolabs
  • Nutribiotech
  • HAOZE Bio
  • Shreeji Pharma International